Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer cells, even after the cancer has spread to other organs.

Tumor treating fields are emerging as a promising option for treating a range of cancer types. Here’s a look at the evidence ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

An HPV vaccine delivered into the nose can treat cervical tumors in mice. The vaccine targets a cancer protein produced by the virus.

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

Nasal nanodrops carrying gold-based spherical nucleic acids can slip into the brain and activate powerful immune pathways ...

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new insights into how the immune makeup of fibrotic tissue may influence ...

Patients in the highest-exposure group, ie, those with more than 385 defined daily doses of PPIs, have an 83% higher risk for gastric neuroendocrine tumors than nonusers.

Jennifer Capasso had endured multiple tumors. She wondered what might be said during her next cancer surgery. So, she hit ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

Posey says the money goes to local families in need, St. Jude's Children's Hospital and the CURE Childhood Cancer ...

Key market opportunities in tumor transcriptomics lie in addressing the growing demand for advanced diagnostic tools due to rising cancer cases. Continuous innovations in genomic sequencing and ...